TG Therapeutics, Inc.

TG Therapeutics, Inc.verified

TGTX

Price:

$16.48

Market Cap:

$2.55B

TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hodgkin lymphoma, chronic lymphocytic leukemia (CLL), and relapsing forms of multiple sclerosis; and Umbralisib, an oral inhibitor of PI3K-delta and CK1-epsilon for the treatment of CLL, marginal zone lymphoma, and follicular lymphoma. The company also develops Cosibelimab, a human monoclonal antibody of IgG1 subtype that binds to programmed death-ligand...[Read more]

Industry

Biotechnology

IPO Date

2010-05-03

Stock Exchange

NASDAQ

Ticker

TGTX

The Current Ratio as of May 2024 (TTM) for TG Therapeutics, Inc. (TGTX) is 3.62

According to TG Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 3.62. This represents a change of -6.67% compared to the average of 3.88 of the last 4 quarters.

TG Therapeutics, Inc. (TGTX) Historical Current Ratio (quarterly & annually)

How has TGTX Current Ratio performed in the past?

The mean historical Current Ratio of TG Therapeutics, Inc. over the last ten years is 5.62. The current 3.62 Current Ratio has changed 6.34% with respect to the historical average. Over the past ten years (40 quarters), TGTX's Current Ratio was at its highest in in the June 2014 quarter at 18.91. The Current Ratio was at its lowest in in the September 2019 quarter at 1.00.

Quarterly (TTM)
Annual

Average

5.62

Median

4.20

Minimum

1.77

Maximum

16.64

TG Therapeutics, Inc. (TGTX) Current Ratio by Quarter and Year

Discovering the peaks and valleys of TG Therapeutics, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 295.60%

Maximum Annual Current Ratio = 16.64

Minimum Annual Increase = -63.48%

Minimum Annual Current Ratio = 1.77

Quarterly (TTM)
Annual
YearCurrent RatioChange
20235.9287.12%
20223.16-37.51%
20215.06-27.55%
20206.99295.60%
20191.77-13.17%
20182.03-39.06%
20173.3410.76%
20163.01-63.48%
20158.25-50.41%
201416.64148.48%

TG Therapeutics, Inc. (TGTX) Average Current Ratio

How has TGTX Current Ratio performed in the past?

The current Current Ratio of TG Therapeutics, Inc. (TGTX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

4.71

5-year avg

4.58

10-year avg

5.62

TG Therapeutics, Inc. (TGTX) Current Ratio vs. Peers

How is TGTX’s Current Ratio compared to its peers?

TG Therapeutics, Inc.’s Current Ratio is less than Madrigal Pharmaceuticals, Inc. (9.39), less than Intercept Pharmaceuticals, Inc. (4.22), less than Terns Pharmaceuticals, Inc. (27.85), greater than Hepion Pharmaceuticals, Inc. (3.31), greater than Exelixis, Inc. (3.46), less than Viking Therapeutics, Inc. (29.48), greater than BioXcel Therapeutics, Inc. (2.57), less than Akero Therapeutics, Inc. (30.12), greater than Reata Pharmaceuticals, Inc. (3.21), less than X4 Pharmaceuticals, Inc. (3.71), less than PDS Biotechnology Corporation (4.56),

Build a custom stock screener for TG Therapeutics, Inc. (TGTX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like TG Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

TG Therapeutics, Inc. (TGTX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like TG Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Current Ratio?

How can you use the Current Ratio?

What is TG Therapeutics, Inc.'s Current Ratio?

How is the Current Ratio calculated for TG Therapeutics, Inc. (TGTX)?

What is the highest Current Ratio for TG Therapeutics, Inc. (TGTX)?

What is the 3-year average Current Ratio for TG Therapeutics, Inc. (TGTX)?

What is the 5-year average Current Ratio for TG Therapeutics, Inc. (TGTX)?

How does the current Current Ratio for TG Therapeutics, Inc. (TGTX) compare to its historical average?